Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with fetal alcohol spectrum disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 4, 2008, Pages 365-371

  Doig, Jenna ^a   McLennan, John D ^b,d   Gibbard, W Ben ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; CARBAMAZEPINE; CLONIDINE; DEXAMPHETAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; RISPERIDONE;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; FEMALE; FETAL ALCOHOL SYNDROME; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; OPPOSITIONAL DEFIANT DISORDER; SYMPTOMATOLOGY;

ADOLESCENT; ALBERTA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEMALE; FETAL ALCOHOL SYNDROME; HOSPITALS, PEDIATRIC; HUMANS; MALE; PREGNANCY; SEVERITY OF ILLNESS INDEX;

EID: 50849111115     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0121     Document Type: Article

References (32)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) Washington DC: American Psychiatric Association, 1994.
2. nd ed. Seattle (Washington): University of Washington, 1999.
3. Astley SJ, Clarren SK: Diagnosing the full spectrum of fetal alcohol-exposed individuals: Introducing the 4-Digit Diagnostic Code. Alcohol 35:400-410, 2000.
4. Biederman J, Milberger S, Farone S, Kiely K, Guite J, Mick E, Ablon S, Warbutron R, Reed E: Family-environment risk factors for attention-deficit hyperactivity disorder: A test of Ruttter's indicators of adversity. Arch Gen Psychiatry 52:464-470, 1995.
5. Brown RT, Coles CD, Smith IE, Platzman KA, Silverstein J, Erickson S, Falek A: Effects of prenatal alcohol exposure at school age. II. Attention and behavior. Neurotoxicol Teratol 13:369-376, 1991.
6. Burd L, Klug MG, Martsolf JT, Kerbeshian J: Fetal alcohol syndrome: Neuropsychiatric phenomics. Neurotox Teratol 25:697-705, 2003.
7. Burden MJ, Jacobson SW, Sokol RJ, Jacobson JL: Effects of prenatal alcohol exposure on working memory at 7.5 years of age. Alcohol Clin Exp Res 29:443-452, 2005.
8. Coe J, Sidders J, Riley K, Waltermire J, Hagerman R: A survey of medication responses in children and adolescents with fetal alcohol syndrome. Ment Health Aspects Dev Disabil 4:148-155, 2001.
9. Coggins T, Timler G, Olswang L: A state of double jeopardy: Impact of prenatal alcohol exposure and adverse environments on the social communicative abilities of school-age children with fetal alcohol spectrum disorder. Lang Speech Hearing Services in Schools 38:117-127, 2007.
10. Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE: A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res 21:150-161, 1997.
11. Coles CD: Fetal alcohol exposure and attention: Moving beyond ADHD. Alcohol Res Health 25:199-203, 2001.
12. Gaub M, Carlson C: Behavioural characteristics of DSM-IV ADHD subtypes in school-based population. J Abnorm Child Psychol 25:103-111, 1997.
13. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March J, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T: Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22:60-73, 2001.
14. Jones KL, Smith DW: Recognition of the fetal alcohol syndrome in early infancy. Lancet 7836:999-1001, 1973.
15. Kodituwakku P, Coriale G, Fiorentino D, Aragon AS, Kalberg WO, Buckley D, Gossage JP, Ceccanti M, May PA: Neurobehavioural characteristics of children with fetal alcohol spectrum disorders in communities from Italy: Preliminary results. Alcohol Clin Exp Res 30:1551-1561, 2006.
16. Lee KT, Mattson SN, Riley EP: Classifying children with heavy prenatal alcohol exposure using measures of attention. J Clin Exp Neuropsychol 10:271-277, 2004.
17. Linnet K, Dalsgaard S, Obel C, Wisborg K, Henriksen T, Rodriguez A, Kotimaa A, Mollanen I, Thomsen PH, Olsen J, Jarvelin MR: Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: Review of the current evidence. Am J Psychiatry 160:1029-1040, 2003.
18. Mattson SN, Riley EP: Parent ratings of behaviour in children with heavy prenatal alcohol exposure and IQ-matched controls. Alcohol Clin Exp Res 24:226-231, 2000.
19. May P, Gossage P, Brooke L, Snell C, Marais AS, Hendricks L: Maternal risk factors for fetal alcohol syndrome in the Western Cape Province of South Africa: A population-based study. Am J Public Health 95: 1190-1199, 2005.
20. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1088-1096, 1999.
21. Nanson JL, Hiscock M: Attention deficits in children exposed to alcohol prenatally. Alcohol Clin Exp Res 14:656-661, 1990.
22. Oesterheld J, Wilson A: ADHD and FAS. J Am Acad Child Adolesc Psychiatry 36:1163, 1997.
23. Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson, A, Fiechtner H: Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: A controlled pilot study. J Child Adolesc Psychopharmacol 8:39-48, 1998.
24. O'Malley KD, Koplin B, Dohner VA: Psychostimulant clinical response in fetal alcohol syndrome. Can J Psychiatry 45:90-91, 2000. (Letter)
25. O'Malley KD, Storoz L: Fetal alcohol spectrum disorder and ADHD: Diagnostic implications and therapeutic consequences. Expert Rev Neurother 3:477-489, 2003.
26. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopex M: The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:642-657, 2006.
27. Snyder J, Nanson J, Snyder R, Block G: A study of stimulant medication in children with FAS. In: The Challenge of Fetal Alcohol Syndrome: Overcoming Secondary Disabilities. Edited by Streissguth AP, Kanter J. Seattle, University of Washington Press, 1997, pp 64-77.
28. Sokol RJ, Delaney-Black V, Nordstrom B: Fetal alcohol spectrum disorder. JAMA 290:2996-2999, 2003.
29. Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. Washington: National Academy Press, 1996.
30. Steinhausen HC, Willms J, Spohr HL: Long-term psychopathological and cognitive outcome of children with fetal alcohol syndrome. J Am Acad Child Adolesc Psychiatry 32:990-994, 1993.
31. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK: Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr 25:228-238, 2004.
32. Swanson J, Kraemer H, Hinshaw S, Arnold LE, Conners CK, Abikoff JW, Clevenger W, Davies M, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigan T, Wu M: Clinical relevance of the primary findings of the MTA: Success rates based on the severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168-179, 2001.